JP3308497B2 - SOD-like extract composition extracted from coffee beans - Google Patents

SOD-like extract composition extracted from coffee beans

Info

Publication number
JP3308497B2
JP3308497B2 JP21173998A JP21173998A JP3308497B2 JP 3308497 B2 JP3308497 B2 JP 3308497B2 JP 21173998 A JP21173998 A JP 21173998A JP 21173998 A JP21173998 A JP 21173998A JP 3308497 B2 JP3308497 B2 JP 3308497B2
Authority
JP
Japan
Prior art keywords
sod
extract
water
coffee beans
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP21173998A
Other languages
Japanese (ja)
Other versions
JP2000023636A (en
Inventor
彰彦 木村
敦士 ▲高▼田
直人 石川
利孝 岡田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Hakko Co Ltd
Original Assignee
Toyo Hakko Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Hakko Co Ltd filed Critical Toyo Hakko Co Ltd
Priority to JP21173998A priority Critical patent/JP3308497B2/en
Publication of JP2000023636A publication Critical patent/JP2000023636A/en
Application granted granted Critical
Publication of JP3308497B2 publication Critical patent/JP3308497B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Tea And Coffee (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、コーヒー豆から抽出さ
れたSOD様抽出組成物に関する。更に詳しくは、本発
明は、活性酸素が原因となる各種の病気、例えば、血流
障害による病気(心筋梗塞、脳卒中、高血圧、生理痛、
肩こり、神経痛、腰痛、二日酔い等)、成人病・内科疾
患(癌、腎炎、肝炎、糖尿病等)、美容・皮膚病(し
み、そばかす、肌荒れ、冷え症、便秘、しわ、アトピー
性皮膚炎等)等の治療、改善等に広く利用され得るSO
D様抽出組成物に関する。
The present invention relates to a SOD-like extract composition extracted from coffee beans. More specifically, the present invention relates to various diseases caused by active oxygen, for example, diseases caused by impaired blood flow (myocardial infarction, stroke, hypertension, menstrual cramps,
Stiff shoulders, neuralgia, back pain, hangovers, etc., adult diseases / medical diseases (cancer, nephritis, hepatitis, diabetes, etc.), beauty and skin diseases (stains, freckles, rough skin, chills, constipation, wrinkles, atopic dermatitis, etc.) That can be widely used for treatment, improvement, etc.
D-like extract composition.

【0002】[0002]

【従来の技術】スーパーオキシドジスムターゼ(以下、
SODという。)は、酸素分子の1電子還元で生成する
スーパーオキシドラジカル(O2 -)の不均化反応(下
式)を拡散律速に近い速さで触媒し、細胞内のO2 -濃度
を低下させる酵素である。 2O2 -+2H+→H22+O22 -に代表される活性酸素種は、通常、生体内において
活性化されたマクロファージなどの食細胞から産生さ
れ、殺菌作用や殺腫瘍作用を示す。しかし、これらの活
性酸素種には選択毒性がなく、正常細胞にも作用できる
結果、生体に対して種々の障害も引き起こすことが知ら
れている。例えば、脂質の過酸化による膜の損傷、タン
パク質の酸化修飾によるタンパク質の構造変化、DNA
の切断等の結果、細胞に障害作用を示し、様々な疾病の
原因ともなることが明らかにされている。
2. Description of the Related Art Superoxide dismutase (hereinafter, referred to as superoxide dismutase)
It is called SOD. ) Catalyzes the disproportionation reaction of the superoxide radical (O 2 ) generated by one-electron reduction of oxygen molecules (the following formula) at a rate close to the diffusion rate, and reduces the intracellular O 2 concentration. It is an enzyme. Reactive oxygen species typified by 2O 2 + 2H + → H 2 O 2 + O 2 O 2 are usually produced from activated phagocytic cells such as macrophages in vivo, and exhibit bactericidal and tumoricidal effects. . However, it is known that these reactive oxygen species do not have selective toxicity and can act on normal cells, resulting in various obstacles to living organisms. For example, membrane damage due to lipid peroxidation, protein structural change due to oxidative modification of protein, DNA
It has been shown that as a result of cleavage and the like, cells show a damaging effect and cause various diseases.

【0003】従って、O2 -の除去酵素であるSODは、
生体を活性酸素種から守るために存在するものであり、
この活性酸素種を起因として生じると考えられる病気等
に有効であるとの観点から、近年、その反応機構、生理
機構等が研究されている〔「活性酸素−生物での生成・
消去・作用の分子機構」(新装版2刷、共立出版株式会
社発行、中野稔ら編著)223〜230頁)〕。また、
癌細胞ではSOD活性が低いという事実があり、更に、
SODと発癌との直接因果関係は明らかではないが、S
OD又はSOD様物質を癌細胞に注入すると、増殖を抑
えるという報告もある(同64頁)。
[0003] Therefore, O 2 - is the removal enzyme of SOD,
It exists to protect the living body from reactive oxygen species,
In view of the fact that it is effective against diseases and the like that are considered to be caused by this reactive oxygen species, its reaction mechanism, physiological mechanism and the like have been studied in recent years.
Molecular Mechanism of Elimination / Action ”(2nd Edition, published by Kyoritsu Shuppan Co., Ltd., edited by Minoru Nakano et al., Pp. 223-230)]. Also,
There is a fact that SOD activity is low in cancer cells.
Although the direct causal relationship between SOD and carcinogenesis is not clear,
There is also a report that injection of OD or SOD-like substance into cancer cells suppresses proliferation (p. 64).

【0004】コーヒー生豆は、タンニン成分であるクロ
ロゲン酸類の他、脂質類、炭水化物類、タンパク質及び
カフェインなど、様々な成分を含んでいる。近年、コー
ヒーが、抗変異原性、酸化防止などの様々な作用効果を
有することが明らかにされており、その応用例として、
例えば、クロロゲン酸類による、ビタミンCの安定化
(特開平6−9603号)、天然香料の劣化防止(特
開平4−345693号)、色素の褐色防止剤(特開
平5−32909号、特公平1−22877号)、フ
レーバーの劣化防止(特開平6−38723号)、胃
粘膜保護用薬剤(特公表63−502349)の他、
β−Alkanoyl−5−hydroxytryp
tamineを含有することを特徴とする抗酸化剤(特
開平8−157816号)、クロロゲン酸を必須成分
として含有するコーヒーノキ種抽出物配合化粧料(特開
平8−92057号)などが知られている。
[0004] Green coffee beans contain various components such as lipids, carbohydrates, proteins and caffeine in addition to chlorogenic acids, which are tannin components. In recent years, coffee has been shown to have various effects such as anti-mutagenicity and antioxidation.
For example, stabilization of vitamin C by chlorogenic acids (JP-A-6-9603), prevention of deterioration of natural fragrances (JP-A-4-345693), browning inhibitor for pigments (JP-A-5-32909, Tokuhei 1) 22877), prevention of deterioration of flavor (Japanese Unexamined Patent Publication No. 6-38723), a gastric mucosa protective agent (Japanese Patent Publication No. 63-502349),
N β -Alkanoyl-5-hydroxytryp
There are known an antioxidant characterized by containing tammine (Japanese Patent Application Laid-Open No. 8-157816), a cosmetic composition containing coffee tree seed extract containing chlorogenic acid as an essential component (Japanese Patent Application Laid-Open No. 8-92057), and the like. .

【0005】[0005]

【発明が解決しようとする課題】安全で且つSOD作用
(活性酸素濃度を減少させる作用のみならず、これに起
因して生じると考えられる種々の病気の予防、改善の作
用をも含む。)を有し、食品等に用いられるものがあれ
ば、人の健康及び美容にとって非常に有用であり、その
必要性は極めて大きい。近年のようにストレスが多く、
それに起因する多くの病気が発生している状況において
は特にその必要性が大きいことから、安全で且つ優れた
SOD作用を有する製品の開発が強く望まれていた。
A safe and SOD action (including not only an action to reduce the concentration of active oxygen, but also an action to prevent and improve various diseases which may be caused by the action). It is very useful for human health and beauty if there is one that has it and is used for foods and the like, and the need for it is extremely large. There is a lot of stress as in recent years,
Since the necessity is particularly large in a situation where many diseases caused by the disease have occurred, development of a product having a safe and excellent SOD action has been strongly desired.

【0006】一方、コーヒーの生理活性に関する近年の
研究は、コーヒー豆中の特定成分を抽出し、その生理活
性を検討するものが多い。しかし、上記のように、コー
ヒー豆中の成分は数多くの物質が含まれているので、そ
れらの全てを分離、同定し、生理活性を検討することは
困難である。また、ある特定成分のみでなく、複数の成
分の相乗効果がある場合も考えられるが、このような相
乗効果に関する知見はまだ十分に得られていないのが現
状である。
[0006] On the other hand, many recent studies on the physiological activity of coffee often involve extracting a specific component from coffee beans and examining the physiological activity. However, as described above, since the components in coffee beans contain many substances, it is difficult to separate and identify all of them and to examine their biological activities. In addition, there may be a case where not only a specific component but also a plurality of components have a synergistic effect. However, at present, knowledge on such a synergistic effect has not yet been sufficiently obtained.

【0007】しかも、生体外で効果が見られた物質を生
体内に経口投与しても、消化器系各所における消化、吸
収過程等が複雑に絡んでいるため、必ずしも同様の効果
を奏するとは限らない。上記応用例のうち〜及び
は、生体外で使用するものであることから、全て生体外
における効果についての知見にすぎず、実際に生体に投
与した場合の効果については何も記載されていない。ま
た、上記応用例は人体へ使用するものではあるが、皮
膚に使用する化粧料であることから、これも実際に生体
に投与した場合の体内動態及び効果については何も記載
されていない。更に、上記応用例では、クロロゲン酸
が生体内に投与されてはいるが、その効果は主に収斂作
用による胃粘膜保護作用、即ち、胃粘膜上でタンパク質
と結合して不溶性沈殿物を作り、それが被膜となって胃
粘膜を保護するものである。従って、この場合は投与さ
れたクロロゲン酸はあまり消化器より吸収されないと考
えられ、コーヒー豆中の成分が消化器より吸収されて、
全身にどのような作用効果を奏するかについては不明で
ある。
[0007] Furthermore, even if a substance that has been shown to be effective in vitro is orally administered to a living body, the digestive and absorption processes in various parts of the digestive system are involved in a complicated manner, so that the same effect is not necessarily achieved. Not exclusively. Since and in the above-mentioned application examples are used in vitro, all are merely findings on in vitro effects, and nothing is described about the effects when actually administered to a living body. In addition, although the above-mentioned application example is used for the human body, it is a cosmetic used for the skin, and therefore, nothing is described about the pharmacokinetics and effect when actually applied to a living body. Further, in the above application example, chlorogenic acid is administered in vivo, but its effect is mainly a gastric mucosal protective effect by an astringent effect, that is, it binds to a protein on the gastric mucosa to form an insoluble precipitate, It forms a coating and protects the gastric mucosa. Therefore, in this case, it is considered that the administered chlorogenic acid is hardly absorbed from the digestive system, and the components in the coffee beans are absorbed from the digestive system,
It is unknown what effect it has on the whole body.

【0008】本発明は、上記現状に鑑みてなされたもの
であり、コーヒー豆を原料として用い、生体内において
安全で且つ優れたSOD作用を有し、特に微量でも効果
を奏するSOD様抽出組成物を提供することを目的とす
る。
The present invention has been made in view of the above-mentioned circumstances, and uses a coffee bean as a raw material, has a safe and excellent SOD action in a living body, and is particularly effective even in a trace amount. The purpose is to provide.

【0009】[0009]

【課題を解決するための手段】以上の観点より、本発明
者等は、コーヒー豆中の様々な成分による複合的な相乗
作用による生理活性に着目して種々検討した所、コーヒ
ー豆を原料とした抽出物が、生体内において微量でもS
OD作用を有することを明らかにし、本発明を完成する
に至ったものである。
In view of the above, the present inventors have conducted various studies focusing on the physiological activity of the complex synergistic action of various components in coffee beans. Of the extracted extract, even in trace amounts in vivo
The present invention has been shown to have an OD action, and the present invention has been completed.

【0010】本第1発明のSOD様抽出組成物は、水、
熱水、エタノール、酢酸エチル、又はエタノール若しく
は酢酸エチルと水若しくは熱水との混合溶媒を抽出溶媒
とし、コーヒー豆から抽出された抽出物(以下、「コー
ヒー豆抽出物」という。)を0.0003〜0.5重量
%含み、生体内においてSOD作用を有することを特徴
とする。上記「コーヒー豆」としては、例えば、アラビ
カ種、ロブスタ種及びリベリカ種等のいずれの品種を用
いてもよく、その産地も特に限定されることはない。ま
た、栽培原地においてコーヒー飲料用として生産された
コーヒー豆は、焙煎用に選別される際に多量の選外品が
分別除去されるが、本発明においてはこの選外品も上記
「コーヒー豆」として使用することができる。上記「コ
ーヒー豆抽出物」としては、抽出液を濾過したままの液
でもよいし、これを脱色等の後処理をした液でもよい
し、これを濃縮した濃縮液でもよい。尚、この抽出物を
噴霧乾燥して粉末としたものを用いてもよい。
The SOD-like extract composition of the first invention comprises water,
Hot water, ethanol, ethyl acetate, or ethanol
Is a solvent mixture of ethyl acetate and water or hot water
And the extract extracted from coffee beans
Hea bean extract. " ) In an amount of 0.0003 to 0.5% by weight, and has an SOD action in vivo. As the above-mentioned "coffee beans", for example, any varieties such as Arabica, Robusta, and Rebellica may be used, and the place of production is not particularly limited. In addition, coffee beans produced for coffee drinks in the cultivation area are sorted and removed in a large amount when the coffee beans are sorted for roasting. Can be used as "beans". The “coffee bean extract” may be a liquid obtained by filtering the extract, a liquid obtained by subjecting the extract to post-treatment such as decolorization, or a concentrated liquid obtained by concentrating the extract. Incidentally, a powder obtained by spray-drying this extract may be used.

【0011】また、上記「コーヒー豆抽出物」を得るた
めの抽出方法については特に制限されるものはない。原
料であるコーヒー豆は未粉砕でも、粉砕したものでもよ
く、抽出物の品質を維持できる限り、不純物除去等の前
処理をしてもよい。抽出溶媒としては、水又は熱水の
他、エタノール、酢酸エチル等の有機溶媒や、これらの
有機溶媒と水又は熱水との混合溶媒でもよい。尚、本抽
出物は水溶性であることから、これらの溶媒のうち、水
(熱水も含む)又はエタノール/水の混合溶媒が好まし
い。抽出条件も特に制限はないが、通常は常温又は加熱
抽出が好ましい。加熱温度及び加熱時間についても、十
分に抽出でき、抽出物の品質を維持できる範囲で種々の
条件とすることができる。更に、上記抽出において、抽
出物の品質を維持できる限り、抽出を補助する物質を添
加することもできる。例えば、プロテアーゼ、セルラー
ゼ等の酵素類の他、L−アスコルビン酸類のような還元
性物質などを加えてもよい。抽出液のpHは、L−アス
コルビン酸類などを加えると、通常は5.0〜6.0を
示すが、抽出物の品質劣化を引き起こさない限り、この
pHには制限はない。
The extraction method for obtaining the above-mentioned "coffee bean extract" is not particularly limited. The raw coffee beans may be unground or ground, and may be subjected to pretreatment such as removal of impurities as long as the quality of the extract can be maintained. The extraction solvent may be water or hot water, or an organic solvent such as ethanol or ethyl acetate, or a mixed solvent of these organic solvents with water or hot water. Since the present extract is water-soluble, among these solvents, water (including hot water) or a mixed solvent of ethanol / water is preferable. The extraction conditions are not particularly limited, but usually, room temperature or heat extraction is preferred. Regarding the heating temperature and the heating time, various conditions can be set as long as the extraction can be sufficiently performed and the quality of the extract can be maintained. Further, in the above-mentioned extraction, substances that assist the extraction can be added as long as the quality of the extract can be maintained. For example, a reducing substance such as L-ascorbic acid may be added in addition to enzymes such as protease and cellulase. The pH of the extract usually shows 5.0 to 6.0 when L-ascorbic acids and the like are added, but there is no limit to this pH as long as the extract does not deteriorate in quality.

【0012】尚、本第1発明のSOD様抽出組成物にお
けるコーヒー豆抽出物濃度が0.5重量%を超えると、
上記SOD作用は頭打ちになる傾向が見られること、及
び、上記SOD作用は特に0.005〜0.5重量%に
おいて顕著に上昇することから、本第1発明のSOD様
抽出組成物におけるコーヒー豆抽出物濃度は0.000
3〜0.5重量%、好ましくは0.005〜0.5重量
%の割合で使用する。
When the coffee bean extract concentration in the SOD-like extract composition of the first invention exceeds 0.5% by weight,
Since the SOD effect tends to reach a plateau and the SOD effect increases particularly at 0.005 to 0.5% by weight, the coffee beans in the SOD-like extract composition of the first invention are Extract concentration is 0.000
It is used in a proportion of 3 to 0.5% by weight, preferably 0.005 to 0.5% by weight.

【0013】本発明のSOD様抽出組成物は、コーヒー
豆抽出物を0.0003〜0.5重量%含み、ニトロブ
ルーテトラゾリウム(以下、NBTという。)還元法に
より測定したSOD活性比1.1〜3.0とすること
ができる
[0013] The SOD-like extract composition of the present invention contains 0.0003 to 0.5% by weight of a coffee bean extract and has an SOD activity ratio of 1. measured by a nitro blue tetrazolium (hereinafter referred to as NBT) reduction method. It is a 1 to 3.0
Can be .

【0014】上記「NBT還元法」とは、キサンチンと
酸素がキサンチンオキシダーゼ存在下反応し、生じたO
2 -がNBTを還元してジホルマザンを生成するという反
応過程において、SOD活性を示す物質が存在すると、
これがO2 -と反応して、O2 -の濃度を低下させる結果、
ジホルマザンの生成量が減少することから、その減少の
程度を阻害率として求めることにより、試料中のSOD
活性を求める方法である。上記「SOD活性比」とは、
以下の実施例に記載された試験方法に基づいて、コーヒ
ー豆抽出物を含まない試料をマウスに経口投与して、得
られた血液試料からNBT還元法により測定したSOD
活性と、所定濃度のコーヒー豆抽出物を含む試料をマウ
スに投与して、得られた血液試料からNBT還元法によ
り測定したSOD活性の比であることを意味する。
The "NBT reduction method" refers to the reaction of xanthine with oxygen in the presence of xanthine oxidase, and
2 - In the reaction process that produces the diformazan by reducing NBT, a substance showing a SOD activity is present,
Results to reduce the concentration of, - which O 2 - react with, O 2
Since the amount of diformazan produced decreases, the degree of the decrease is determined as the inhibition rate, and the SOD in the sample is determined.
This is a method to determine the activity. The “SOD activity ratio” is
Based on the test method described in the following example, a sample containing no coffee bean extract was orally administered to mice, and SOD measured by an NBT reduction method from the obtained blood sample.
It means the ratio between the activity and the SOD activity measured by the NBT reduction method from a blood sample obtained by administering a sample containing a coffee bean extract at a predetermined concentration to a mouse.

【0015】本発明のSOD様抽出組成物は、NBT還
元法により測定したSOD活性比が1.1〜3.0の値
を示すものとすることができる。特に、SOD様抽出組
成物中のコーヒー豆抽出物濃度は0.0003〜0.0
5重量%という低濃度でも、NBT還元法により測定し
たSOD活性比が1.1〜1.7の値を示すものとする
ことができる。本第1発明のコーヒー豆抽出物は、生体
内におけるSOD作用に優れることから、活性酸素が原
因となる病気を治療する治療用組成物として用いること
ができる。また、本第発明に示すように、水溶性飲料
又は食品添加組成物として用いることができる。
[0015] The SOD-like extract composition of the present invention can have an SOD activity ratio of 1.1 to 3.0 as measured by the NBT reduction method. In particular, the coffee bean extract concentration in the SOD-like extract composition is 0.0003-0.0
Even at a concentration as low as 5% by weight, the SOD activity ratio measured by the NBT reduction method can exhibit a value of 1.1 to 1.7. The coffee bean extract of the first invention is excellent in SOD action in a living body, and thus can be used as a therapeutic composition for treating a disease caused by active oxygen. Further, as shown in the second invention, it can be used as a water-soluble beverage or a food additive composition.

【0016】[0016]

【発明の実施の形態】以下実施例により本発明を具体的
に説明する。 (1)SOD様抽出組成物の製造 コーヒー豆100kg(種類:Java、インドネシア
産)を相互式粉砕機(相互産業株式会社製)により粉砕
し、この粉砕豆に10000ガウスの磁力を通して金属
異物を除去する。次に、この粉砕豆に対して、水を5倍
量混入し、さらにクエン酸0.02%、L−アスコルビ
ン酸0.15%攪拌しながら添加してpHを5.6〜
6.0とし、溶けたら攪拌を止めて加熱せずに一晩放置
して抽出する。そして、遠心分離器にて、この抽出液か
ら固形物を取り除く。引き続き、抽出液をタンクに移
し、理論上の粉砕豆量に対して0.06%の活性炭を混
合し、50℃に加熱し、30分間攪拌して脱色する。そ
の後、プレコートとしてろ過器内に0.5〜1.5kg
のケイソウ土を使用し、ボディーコートとして抽出エキ
スに約1.8kgのケイソウ土を使用してろ過を行っ
て、コーヒー豆抽出物を製造した。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be specifically described below with reference to examples. (1) Production of SOD-Like Extraction Composition 100 kg of coffee beans (type: Java, produced in Indonesia) is pulverized by an interactive pulverizer (manufactured by Mutual Sangyo Co., Ltd.), and the pulverized beans are passed through a magnetic force of 10,000 Gauss to remove metallic foreign substances I do. Next, 5 times the amount of water was added to the ground beans, and 0.02% of citric acid and 0.15% of L-ascorbic acid were added with stirring to adjust the pH to 5.6 to 5.6.
When the mixture is dissolved, stop stirring and leave it overnight without heating to extract. Then, solids are removed from the extract with a centrifuge. Subsequently, the extract is transferred to a tank, mixed with activated carbon in an amount of 0.06% based on the theoretical amount of ground beans, heated to 50 ° C., and stirred for 30 minutes to be decolorized. Then, as a pre-coat 0.5-1.5kg in the filter
Diatomaceous earth was used as a body coat, and about 1.8 kg of diatomaceous earth was used as a body extract for filtration to produce a coffee bean extract.

【0017】上記コーヒー豆抽出物を噴霧乾燥して粉末
とした後、この粉末を蒸留水に溶解して、以下の濃度の
SOD様抽出組成物を供試試料として調整した。 試験群1の供試試料:0.0005%(W/V)水溶液 試験群2の供試試料:0.005%(W/V)水溶液 試験群3の供試試料:0.05%(W/V)水溶液 試験群4の供試試料:0.5%(W/V)水溶液 試験群5の供試試料:5.0%(W/V)水溶液
After the above coffee bean extract was spray-dried to obtain a powder, the powder was dissolved in distilled water to prepare a SOD-like extract composition having the following concentrations as a test sample. Test sample of test group 1: 0.0005% (W / V) aqueous solution Test sample of test group 2: 0.005% (W / V) aqueous solution Test sample of test group 3: 0.05% (W / V) aqueous solution Test sample of test group 4: 0.5% (W / V) aqueous solution Test sample of test group 5: 5.0% (W / V) aqueous solution

【0018】(2)試験方法 供試動物として、6週齢のウイスター系ラット(5週齢
のものを日本エスエルシー(株)より購入)を、オス6
0匹、メス60匹使用した。上記ウイスター系ラットを
7日間の予備飼育後、一群20匹(オス、メス各10匹
ずつ)とし、6群(対照群及び試験群1〜5)に分け
た。そして、室温23±1℃、湿度45〜55%、12
時間照明(8時〜20時)の条件下にて28日間飼育し
た。試験期間中、対照群及び各試験群に、上記供試試料
1.0ml/日/ラットを胃ゾンデを用いて強制経口投
与した。対照群には同量の蒸留水を経口投与した。給与
飼料として、オリエンタル酵母工業株式会社製「オリエ
ンタルMF」を用いて自由摂取とし、水は蒸留水を自由
飲水させた。そして、試験最終日に心臓より採血し、血
清中のSOD活性及び過酸化脂質値を測定した。
(2) Test method As test animals, 6-week-old Wistar rats (5-week-old rats purchased from Japan SLC, Inc.) were used as males.
0 and 60 females were used. After pre-breeding the Wistar rats for 7 days, the rats were divided into 20 groups (10 males and 10 females) each, and the rats were divided into 6 groups (control group and test groups 1 to 5). And room temperature 23 ± 1 ° C., humidity 45-55%, 12
The animals were reared for 28 days under the conditions of time illumination (8:00 to 20:00). During the test period, 1.0 ml / day / rat of the test sample was orally administered to the control group and each test group using a gastric probe. The same amount of distilled water was orally administered to the control group. Oriental Yeast Kogyo Co., Ltd. "Oriental MF" was used as a feed for free intake, and distilled water was freely supplied. On the last day of the test, blood was collected from the heart, and the SOD activity and lipid peroxide level in the serum were measured.

【0019】(3)SOD活性及び過酸化脂質量の測定 上記により得られた血液試料から、以下に示す測定方法
によりSOD活性及び過酸化脂質量を測定した。SOD
活性は、測定キットとして和光純薬工業製「SODテス
トワコー」(体外診断用医薬品、承認番号(63AM)
第0285号)を用いて、上記NBT還元法により測定
した。その結果を表1、図1及び図3に示す。尚、「S
OD活性比」とは、すでに説明したように、対照群のS
OD活性に対する、各試験群のSOD活性の比である。
(3) Measurement of SOD activity and lipid peroxide content From the blood sample obtained as described above, SOD activity and lipid peroxide content were measured by the following measurement methods. SOD
The activity was determined by measuring the activity of the kit using "SOD Test Wako" (manufactured by Wako Pure Chemical Industries, Inc., an in vitro diagnostic drug, approval number (63AM)).
No. 0285) by the above-mentioned NBT reduction method. The results are shown in Table 1, FIG. 1 and FIG. Note that "S
As described above, the “OD activity ratio” refers to the S value of the control group.
The ratio of the SOD activity of each test group to the OD activity.

【0020】過酸化脂質は、測定キットとして和光純薬
工業製「過酸化脂質−テストワコー(蛍光八木法)」
(体外診断用医薬品、承認番号(61AM)第4641
号)を用いて、チオバルビツール酸(以下、TBAとい
う。)法により測定した。この方法は、過酸化脂質をT
BAとを酸性条件下で加熱することにより生成する赤色
物質の蛍光強度を測定することにより、過酸化脂質濃度
を求めるものである。その結果を表2、図2及び図4に
示す。尚、「過酸化脂質濃度比」とは、対照群の過酸化
脂質濃度に対する、各試験群の過酸化脂質濃度の比であ
る。
[0021] Lipid peroxide is available as a measurement kit "Lipid peroxide-Test Wako (Fluorescent Yagi method)" manufactured by Wako Pure Chemical Industries.
(In Vitro Diagnostic Drug, Approval Number (61AM) No. 4641
No.) and the thiobarbituric acid (hereinafter referred to as TBA) method. This method converts lipid peroxide to T
The concentration of lipid peroxide is determined by measuring the fluorescence intensity of a red substance produced by heating BA with acidic conditions. The results are shown in Table 2, FIG. 2 and FIG. The “lipid peroxide concentration ratio” is the ratio of the lipid peroxide concentration of each test group to the lipid peroxide concentration of the control group.

【0021】(4)試験結果 表1より、SOD活性は対照群と比較していずれの試験
群でも高く、有意差(P<0.01)が認められたこと
から、供試したSOD様抽出組成物は、体内の活性酸素
消去能を有意に高めることが示された。また、図1のグ
ラフより、コーヒー豆抽出物濃度が0.005〜0.5
重量%では、SOD活性比の増加割合が大きいことが分
かる。一方、コーヒー豆抽出物濃度が0.5重量%を超
えると、SOD活性の上昇が頭打ちとなることが示され
ているので、SOD活性を高めるのに適当なコーヒー豆
抽出物濃度の上限が存在することが分かる。更に、図3
のグラフより、コーヒー豆抽出物濃度が0.0005重
量%の場合、0.005重量%及び0.05重量%と比
較して、SOD活性比の急激な上昇が見られることが分
かる。即ち、本発明に係る抽出組成物は極微量であって
も、対照群と比較してSOD活性を有意に高めるという
のが、本発明に係る抽出組成物の大きな特徴の一つであ
る。
(4) Test Results From Table 1, the SOD activity was higher in all test groups than in the control group, and a significant difference (P <0.01) was observed. The composition was shown to significantly enhance the ability of the body to scavenge active oxygen. From the graph of FIG. 1, the coffee bean extract concentration was 0.005 to 0.5.
It can be seen that the percentage by weight of the SOD activity ratio is large when the weight% is used. On the other hand, it has been shown that when the coffee bean extract concentration exceeds 0.5% by weight, the increase in SOD activity reaches a plateau, so that there is an upper limit of the coffee bean extract concentration suitable for increasing SOD activity. You can see that Further, FIG.
It can be seen from the graph that a sharp increase in the SOD activity ratio is observed when the coffee bean extract concentration is 0.0005% by weight, as compared to 0.005% by weight and 0.05% by weight. That is, it is one of the great features of the extract composition according to the present invention that the SOD activity is significantly increased as compared with the control group even if the extract composition according to the present invention is in a very small amount.

【0022】過酸化脂質は活性酸素障害的疾患の指標と
なるものであり、その程度がひどければ増加するもので
ある。表2より、測定の結果、試験群はいずれも対照群
と比較して過酸化脂質量が有意に低下していることが認
められた(試験群1〜5:P<0.05)。また、図2
のグラフより、コーヒー豆抽出物濃度が0.005〜
0.5重量%では、脂質の酸化の抑制割合が大きいこと
が分かる。一方、コーヒー豆抽出物濃度が0.5重量%
を超えると、脂質の酸化抑制が鈍化する傾向が見られ
た。このことは、上記SOD活性の場合と同様に、脂質
の酸化を抑制するのに適当なコーヒー豆抽出物濃度の上
限が存在することを示している。更に、図4のグラフよ
り、コーヒー豆抽出物濃度が0.0005重量%の場
合、0.005重量%及び0.05重量%と比較して、
過酸化脂質濃度が急激に減少していることが分かる、即
ち、本抽出物は極微量であっても、対照群と比較して脂
質の酸化を抑制することが、上記SOD活性の場合と同
様に、本発明に係る抽出組成物の大きな特徴の一つであ
る。
[0022] Lipid peroxide is an index of a disorder of active oxygen disorder, and increases when its degree is severe. From Table 2, as a result of the measurement, it was confirmed that the amount of lipid peroxide in each of the test groups was significantly lower than that in the control group (test groups 1 to 5: P <0.05). FIG.
According to the graph, the coffee bean extract concentration was 0.005 to
It can be seen that at 0.5% by weight, the rate of inhibition of lipid oxidation is large. On the other hand, the coffee bean extract concentration was 0.5% by weight.
When the ratio exceeds, the tendency of lipid oxidation suppression to slow was observed. This indicates that there is an upper limit of the coffee bean extract concentration that is suitable for suppressing lipid oxidation, as in the case of the above-mentioned SOD activity. Furthermore, from the graph of FIG. 4, when the coffee bean extract concentration is 0.0005% by weight, compared with 0.005% by weight and 0.05% by weight,
It can be seen that the lipid peroxide concentration is rapidly decreasing, that is, even when the extract is in a very small amount, the suppression of lipid oxidation as compared to the control group is the same as in the case of the above SOD activity. One of the major features of the extraction composition according to the present invention is that it has a great advantage.

【0023】以上の結果より、本発明に係る抽出組成物
を摂取することにより、体内のSOD活性が高められる
と共に、脂質の酸化が抑制されたことが分かる。また、
本発明に係る抽出組成物のいずれの成分にも有害成分及
び重金属は認められず、特に本発明に係る抽出組成物は
完全な天然物を原料としているため、安全であるといえ
る。そして、上記結果に示すように、本発明に係る抽出
組成物はSOD作用に優れるので、血圧抑制効果等のS
OD作用に起因する効果を有するものと考えられる。ま
た、本発明に係る抽出組成物に含まれるコーヒー豆抽出
物は水溶性のため、上記の試験に示すように水に溶解さ
せて水溶液飲料、食品等として使用することができ、そ
のため体内での吸収に優れるといえる。
From the above results, it can be seen that the ingestion of the extract composition according to the present invention increased the SOD activity in the body and suppressed the oxidation of lipids. Also,
No harmful components and heavy metals are found in any of the components of the extraction composition according to the present invention. In particular, the extraction composition according to the present invention is safe because it is made from a completely natural product. And, as shown in the above results, since the extract composition according to the present invention is excellent in SOD action, S
It is considered to have an effect due to the OD action. In addition, the coffee bean extract contained in the extract composition according to the present invention is water-soluble, and can be used as an aqueous beverage, food, etc. by dissolving in water as shown in the above test, and It can be said that it is excellent in absorption.

【0024】尚、本発明においては、上記具体的実施例
に示すものに限られず、目的、用途に応じて本発明の範
囲内で種々変更した実施例とすることができる。即ち、
上記抽出物の形態は、通常、上記実施例に示すように水
溶液若しくは原液等の液状であるが、これに限らず、こ
の抽出物を吸液性粉末に含浸させた粉末品、造粒した造
粒品、増量剤等他の粉末成分を配合した錠剤、又はマイ
クロカプセル等とすることができる。また、これらの水
溶液、粉末品等を所定容器に充填してなる商品形態、ま
たこれ単独で使用するか他剤(水溶液のもの、油性液の
もの若しくは粉末を問わない。)に配合して使用するか
についても特に限定されず、例えば、ポーション型でも
よいし、他形状容器に充填してもよいし、粉末品をステ
ィック状容器(袋)に充填したものでもよい。更に、従
来の清涼飲料水、ドリンク剤、乳製品、油剤化製品等に
配合、分散して使用してもよい。尚、この分散は油中水
型、水中油型を問わない。また、他の栄養成分(例え
ば、各種ビタミン類、カルシウムイオン成分、鉄イオン
成分等)、薬効成分、調味成分、匂い成分等を配合して
もよい。これらのうち、特に水溶性成分が好ましい。均
一に溶解した商品とすることができるからである。
The present invention is not limited to the specific embodiments described above, but may be variously modified within the scope of the present invention according to the purpose and application. That is,
The form of the extract is usually a liquid such as an aqueous solution or an undiluted solution as shown in the above examples, but is not limited to this. A powder product obtained by impregnating the extract with an absorbent powder, a granulated product Tablets, microcapsules, and the like, into which other powder components such as granules, extenders, and the like are blended can be used. Further, these aqueous solutions, powdered products and the like are filled in a predetermined container in a commercial form, or used alone or mixed with other agents (whether aqueous solution, oily liquid or powder). There is no particular limitation as to whether or not to do so. For example, it may be a potion type, may be filled in a container of another shape, or may be a product in which a powdery product is filled in a stick-shaped container (bag). Furthermore, it may be blended and dispersed in conventional soft drinks, drinks, dairy products, oil products, and the like. In addition, this dispersion does not ask whether it is a water-in-oil type or an oil-in-water type. Further, other nutrient components (for example, various vitamins, calcium ion components, iron ion components, etc.), medicinal components, seasoning components, odor components, and the like may be blended. Of these, water-soluble components are particularly preferred. This is because the product can be uniformly dissolved.

【0025】[0025]

【発明の効果】本発明に係る抽出組成物は、生体内にお
けるSOD作用に優れることから、SOD作用に起因す
る効果(例えば、血圧抑制効果等)に有効である。従っ
て、本発明に係る抽出組成物は、活性酸素種が原因とな
る各種の病気、例えば、血流障害による病気(心筋梗
塞、脳卒中、高血圧、生理痛、肩こり、神経痛、腰痛、
二日酔い等)、成人病・内科疾患(癌、腎炎、肝炎、糖
尿病等)、美容・皮膚病(しみ、そばかす、肌荒れ、冷
え症、便秘、しわ、アトピー性皮膚炎等)等の治療、改
善等に優れた効果を発揮するものと考えられる。
The extract composition according to the present invention is excellent in the SOD action in a living body, and therefore is effective for the effects (for example, blood pressure suppressing effect) caused by the SOD action. Therefore, the extract composition according to the present invention provides various diseases caused by reactive oxygen species, for example, diseases due to impaired blood flow (myocardial infarction, stroke, hypertension, menstrual pain, stiff shoulder, neuralgia, back pain,
Hangover), treatment and improvement of adult diseases and medical diseases (cancer, nephritis, hepatitis, diabetes, etc.), beauty and skin diseases (stains, freckles, rough skin, coldness, constipation, wrinkles, atopic dermatitis, etc.) It is considered that it exerts an excellent effect.

【0026】また、本発明に係る抽出組成物に含まれる
コーヒー豆抽出物は水溶性であることから、吸収効果に
優れると共に、経口投与により簡易に摂取でき、更に、
極微量でもSOD作用を発揮することから、大量に添加
する必要もない。その結果、水溶性飲料、あるいは食品
等の広い分野において利用されることが考えられる。更
に、本発明に係る抽出組成物は完全な天然物を原料とし
ていることから、有害な成分及び重金属は認められず安
全である。
Further, the coffee bean extract contained in the extract composition of the present invention is water-soluble, so that it has an excellent absorption effect and can be easily ingested by oral administration.
Since the SOD action is exhibited even in a very small amount, it is not necessary to add a large amount. As a result, it can be considered to be used in a wide range of fields such as water-soluble beverages and foods. Furthermore, since the extraction composition according to the present invention uses completely natural products as raw materials, it is safe without harmful components and heavy metals.

【図面の簡単な説明】[Brief description of the drawings]

【図1】コーヒー豆抽出物の濃度とSOD活性比との関
係を示した片対数グラフである。
FIG. 1 is a semilogarithmic graph showing the relationship between the concentration of a coffee bean extract and the SOD activity ratio.

【図2】コーヒー豆抽出物の濃度と過酸化脂質濃度比と
の関係を示した片対数グラフである。
FIG. 2 is a semilogarithmic graph showing a relationship between a concentration of a coffee bean extract and a lipid peroxide concentration ratio.

【図3】コーヒー豆抽出物の濃度が0〜0.005重量
%の範囲での、コーヒー豆抽出物の濃度とSOD活性比
との関係を示したグラフである。
FIG. 3 is a graph showing the relationship between the coffee bean extract concentration and the SOD activity ratio when the coffee bean extract concentration is in the range of 0 to 0.005% by weight.

【図4】コーヒー豆抽出物の濃度が0〜0.005重量
%の範囲での、コーヒー豆抽出物の濃度と過酸化脂質濃
度比との関係を示したグラフである。
FIG. 4 is a graph showing the relationship between the coffee bean extract concentration and the lipid peroxide concentration ratio when the coffee bean extract concentration is in the range of 0 to 0.005% by weight.

【表1】 [Table 1]

【表2】 [Table 2]

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 平10−120696(JP,A) (58)調査した分野(Int.Cl.7,DB名) A23L 1/30 A61K 35/78 JICSTファイル(JOIS)──────────────────────────────────────────────────続 き Continuation of the front page (56) References JP-A-10-120696 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A23L 1/30 A61K 35/78 JICST file ( JOIS)

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 水、熱水、エタノール、酢酸エチル、又
はエタノール若しくは酢酸エチルと水若しくは熱水との
混合溶媒を抽出溶媒とし、コーヒー豆から抽出された抽
出物を0.0003〜0.5重量%含み、SOD作用を
有することを特徴とするSOD様抽出組成物。
An extract extracted from coffee beans using water, hot water, ethanol, ethyl acetate, or a mixed solvent of ethanol or ethyl acetate and water or hot water as an extraction solvent, and extracting an extract from coffee beans in an amount of 0.0003 to 0.5. An SOD-like extract composition, which has an SOD effect by weight.
【請求項2】 水、熱水、エタノール、酢酸エチル、又
はエタノール若しくは酢酸エチルと水若しくは熱水との
混合溶媒を抽出溶媒とし、コーヒー豆から抽出された抽
出物を0.0003〜0.5重量%含み、SOD作用を
することを特徴とする水溶性飲料又は食品添加組成
2. An extract extracted from coffee beans using water, hot water, ethanol, ethyl acetate, or a mixed solvent of ethanol or ethyl acetate and water or hot water as an extraction solvent, wherein the extract extracted from coffee beans is 0.0003 to 0.5. wherein wt% water-soluble beverage or food additive composition characterized by <br/> have a SOD activity
Thing .
JP21173998A 1998-07-10 1998-07-10 SOD-like extract composition extracted from coffee beans Expired - Lifetime JP3308497B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21173998A JP3308497B2 (en) 1998-07-10 1998-07-10 SOD-like extract composition extracted from coffee beans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21173998A JP3308497B2 (en) 1998-07-10 1998-07-10 SOD-like extract composition extracted from coffee beans

Publications (2)

Publication Number Publication Date
JP2000023636A JP2000023636A (en) 2000-01-25
JP3308497B2 true JP3308497B2 (en) 2002-07-29

Family

ID=16610794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21173998A Expired - Lifetime JP3308497B2 (en) 1998-07-10 1998-07-10 SOD-like extract composition extracted from coffee beans

Country Status (1)

Country Link
JP (1) JP3308497B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005206502A (en) * 2004-01-21 2005-08-04 Toyo Hakko:Kk Apoptosis-inducing agent, food, drink and medicine containing the same and method for producing apoptosis-inducing agent

Also Published As

Publication number Publication date
JP2000023636A (en) 2000-01-25

Similar Documents

Publication Publication Date Title
WO2013100105A1 (en) Maillard reaction inhibitor
JP2012051940A (en) Beverage/food and medicine comprising loquat leaf extract
JP2001200250A (en) Antioxidant
FR2822381A1 (en) New superoxide dismutase compositions, used for e.g. prevention and treatment allergies, inflammatory disorders, and degenerative disorders, comprise Cucumis melo extract and a liposoluble fatty material
JP2955126B2 (en) Pharmaceutical oleaginous preparation, food oleaginous preparation and production method thereof
JP2006347952A (en) Anthraquinone derivative exerting lipase activating effect and antiobesity drug, food preparation and cosmetic comprising the same
JP3284097B2 (en) Biological antioxidant function enhancer
KR20160021734A (en) Antioxidative composition comprising extract of red tea stem
JPH0840B2 (en) Active oxygen suppressing composition, method for producing the same, and blood pressure suppressing agent
JP3308497B2 (en) SOD-like extract composition extracted from coffee beans
JP5101769B2 (en) Antibiotic antioxidant or preventive agent
JP2009280514A (en) Organic acid peptide-bonded luteolin derivative exhibiting anti-oxidizing action and method for producing the same
JP3404235B2 (en) Anti-obesity agent
JP2002235084A (en) Antioxidant
JPH08283171A (en) Anti-active oxygen agent
JP2001181197A (en) Olive extract
JP6300102B2 (en) Dihydrokaempferol derivative having lipolytic action and process for producing the same
JP4651822B2 (en) SOD-like composition and blood pressure suppressor
JP3455436B2 (en) How to make antioxidants
JPH0881381A (en) Health and beauty-promoting agent having sod action, blood pressure-suppressing agent and constipation-improving agent
JP6228211B2 (en) Compositions for cognitive and cosmetic purposes and use of the compositions for preparing active agents
JP2006016340A (en) Blood uric acid level reduction agent having extract of punica granatum l. as active ingredient
JP2000072686A (en) Active-oxygen scavenger and composition including the same
JP3936245B2 (en) Antihypertensive
KR102588022B1 (en) Antioxidant composition containing apo-9&#39;-fucoxanthinone compound

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090517

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100517

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110517

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120517

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130517

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140517

Year of fee payment: 12

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term